Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aminoglycoside nephrotoxicity

S K Swan1

  • 1Department of Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis 55415, USA.

Seminars in Nephrology
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Aminoglycoside antibiotics, crucial for severe gram-negative infections, can cause kidney injury. Once-daily dosing may enhance efficacy and reduce toxicity by optimizing drug levels and minimizing exposure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis.

Clinical nephrology·2010
Same author

Effect of ketoconazole on the pharmacokinetics and safety of telithromycin and clarithromycin in older subjects with renal impairment.

International journal of clinical pharmacology and therapeutics·2005
Same author

Cyclooxygenase-2 and atherosclerosis: friend or foe?

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2001
Same author

Pharmacokinetics of pilocarpine in subjects with varying degrees of renal function.

Journal of clinical pharmacology·2001
Same author

Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2000
Same author

Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects.

Pharmacotherapy·2000
Same journal

Current Options for Kidney Protection: Are Renin-Angiotensin System Inhibitors Still Relevant?

Seminars in nephrology·2026
Same journal

Proposed Role for Quantitative Podocyturia as a Clinical Marker of Systemic Endothelial Injury: Implications for Cardiovascular Disease and Longevity.

Seminars in nephrology·2026
Same journal

Kidney Protection Options in 2025: Are Renin-Angiotensin System Inhibitors Still Needed?

Seminars in nephrology·2026
Same journal

From Nephron Number to Global Health.

Seminars in nephrology·2026
Same journal

Chronic Kidney Disease Progression Mechanisms: Why They Matter in an Era of Novel Kidney Protective Therapies.

Seminars in nephrology·2026
Same journal

Of Diuretics, Transporters, and Mechanisms of Hypertension.

Seminars in nephrology·2026
See all related articles

Area of Science:

  • Pharmacology
  • Nephrology
  • Infectious Diseases

Background:

  • Aminoglycoside antibiotics are vital for treating severe gram-negative infections.
  • Nephrotoxicity occurs in 10-20% of therapeutic courses, necessitating strategies to minimize renal injury.
  • Current therapeutic drug monitoring has not consistently reduced aminoglycoside toxicity.

Purpose of the Study:

  • To review the mechanisms of aminoglycoside-induced nephrotoxicity.
  • To evaluate the pharmacological parameters influencing aminoglycoside efficacy and toxicity.
  • To explore the potential of modified dosing regimens to improve safety and effectiveness.

Main Methods:

  • Review of existing literature on aminoglycoside pharmacology, nephrotoxicity, and clinical trial data.

Related Experiment Videos

  • Analysis of the relationship between drug levels (peak and trough) and clinical outcomes.
  • Evaluation of once-daily dosing strategies in the context of concentration-dependent killing and post-antibiotic effects.

    • Main Results:

    • Aminoglycosides are filtered by glomeruli and reabsorbed in proximal tubules, leading to intracellular accumulation and potential phospholipid disruption.
    • Peak levels correlate with efficacy (concentration-dependent killing), while trough levels indicate nephrotoxicity risk.
    • Once-daily dosing leverages concentration-dependent killing and post-antibiotic effects, potentially reducing nephrotoxicity by minimizing repeated exposure.

    Conclusions:

    • Understanding aminoglycoside pharmacokinetics and pharmacodynamics is crucial for optimizing therapy.
    • Once-daily dosing presents a promising strategy to balance efficacy and nephrotoxicity.
    • Further research is needed to establish specific guidelines for modified dosing regimens in diverse patient populations and infections.